SFM
CBIO
Sphera Funds Management’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q2 | – | Sell |
-311,013
| Closed | -$3.88M | – | 94 |
|
2019
Q1 | $3.88M | Buy |
311,013
+60,000
| +24% | +$748K | 0.35% | 63 |
|
2018
Q4 | $2.38M | Hold |
251,013
| – | – | 0.27% | 67 |
|
2018
Q3 | $3.62M | Buy |
251,013
+11,080
| +5% | +$160K | 0.42% | 72 |
|
2018
Q2 | $3.87M | Buy |
239,933
+89,933
| +60% | +$1.45M | 0.53% | 54 |
|
2018
Q1 | $2.44M | Sell |
150,000
-175,000
| -54% | -$2.84M | 0.37% | 69 |
|
2017
Q4 | $5.46M | Buy |
+325,000
| New | +$5.46M | 0.64% | 32 |
|
2017
Q3 | – | Sell |
-320,796
| Closed | -$3.58M | – | 128 |
|
2017
Q2 | $3.58M | Sell |
320,796
-455,000
| -59% | -$5.08M | 0.61% | 45 |
|
2017
Q1 | $4.21M | Buy |
775,796
+30,000
| +4% | +$163K | 0.82% | 24 |
|
2016
Q4 | $4.55M | Buy |
745,796
+27,716
| +4% | +$169K | 1.15% | 19 |
|
2016
Q3 | $5.13M | Hold |
718,080
| – | – | 0.84% | 24 |
|
2016
Q2 | $5.22M | Buy |
718,080
+380,169
| +113% | +$2.76M | 1.36% | 15 |
|
2016
Q1 | $2.01M | Buy |
+337,911
| New | +$2.01M | 0.44% | 43 |
|
2014
Q2 | – | Sell |
-106,000
| Closed | -$1.73M | – | 95 |
|
2014
Q1 | $1.73M | Buy |
+106,000
| New | +$1.73M | 0.4% | 53 |
|